Ignite Creation Date:
2024-05-06 @ 8:18 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06326242
Status:
RECRUITING
Last Update Posted:
2024-03-22
First Post:
2024-03-13
Brief Title:
What Unmet Need for the PatientsA Focus on the Social Determinants of Health in Phase 1 Clinical Trials
Sponsor:
European Institute of Oncology
Organization:
European Institute of Oncology
Study Overview
Official Title:
Toward a Patient-centered Early Drug Development in Oncology What Unmet Need for the Patients A Focus on the Social Determinants of Health in Phase 1 Clinical Trials
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
An observational prospective study of patients enrolled and treated with experimental drugs in Phase I studies
Detailed Description:
The study focuses on defining the problem of geographical accessibility of patients to the Phase 1 facility of the European Institute of Oncology based on an anonymized extraction of data from the enrolled patient database to assess national territorial disparities in access to innovative experimental therapies in relation to various socioeconomic determinants Finally information on relevant psychological factors for participation in clinical trials will also be collected
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None